This product image provided by Sanofi shows Lantus SoloStar, the French drugmaker’s once-daily insulin in a pen-like injector. Sanofi on Monday, Sept.
Sanofi settles lawsuit enabling rival to Lantus insulin
by Research Team | Sep 29, 2015 | Health News | 0 comments